Keck School Faculty

Adam Garsa, MD
Adam Garsa, MD
Assistant Professor Of Clinical Radiation Oncology
Radiation Oncology
GNH 1100 N. State Street Health Sciences Campus Los Angeles
Dr.Garsa is an Assistant Professor of Clinical Radiation Oncology at USC Norris Cancer Hospital and USC + Los Angeles County Medical Center. He joined USC in June 2017.

Dr. Garsa graduated with honors from Washington University in St. Louis with a Bachelor of Arts degree in biology. He received his medical degree from the University of Pittsburgh School of Medicine, and completed his residency in radiation oncology at Washington University School of Medicine. In addition, he competed a CNS radiation oncology fellowship in at the University of California San Francisco.

After completing his clinical fellowship, Dr. Garsa was on the faculty at UCSF specializing in the treatment of head and neck, CNS, skin, and lung cancers. Dr. Garsa has presented and published multiple studies investigating advanced imaging technologies and radiation therapy techniques to allow for maximal therapeutic effect while minimizing treatment side effects.

Clinical Expertise: Head and Neck, CNS, Skin Cancer, and SBRT

Bevacizumab is more effective in nasopharyngeal carcinoma patients with lower maximum radiation dose to the temporal lobe Chin Clin Oncol. 2019 Apr 17. . View in PubMed

Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension Laryngoscope. 2018 Oct; 128(10):2226-2233. . View in PubMed

Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging Head Neck. 2018 Oct; 40(10):2280-2287. . View in PubMed

Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging Head Neck. 2018 Jul 26. . View in PubMed

Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy J Appl Clin Med Phys. 2018 Jul; 19(4):48-57. . View in PubMed

Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy Head Neck. 2018 Jul; 40(7):1406-1414. . View in PubMed

Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer Head Neck. 2018 May; 40(5):904-916. . View in PubMed

Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy J Appl Clin Med Phys. 2018 Apr 26. . View in PubMed

Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS) Adv Radiat Oncol. 2018 Apr-Jun; 3(2):146-153. . View in PubMed

Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy Head Neck. 2018 Mar 10. . View in PubMed

Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension Laryngoscope. 2018 Feb 10. . View in PubMed

Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension Laryngoscope. 2018 10; 128(10):2226-2233. . View in PubMed

Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy Head Neck. 2018 07; 40(7):1406-1414. . View in PubMed

Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer Head Neck. 2018 05; 40(5):904-916. . View in PubMed

Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer Head Neck. 2017 Dec 06. . View in PubMed

A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck Cancer. 2017 Jun 01; 123(11):2054-2060. . View in PubMed

A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck Cancer. 2017 06 01; 123(11):2054-2060. . View in PubMed

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy Front Surg. 2017; 4:35. . View in PubMed

J Med Imaging Radiat Oncol. 2016 Aug; 60(4):560-7. . View in PubMed

Transperineal ultrasound-guided implantation of electromagnetic transponders in the prostatic fossa for localization and tracking during external beam radiation therapy Pract Radiat Oncol. 2014 Nov-Dec; 4(6):415-21. . View in PubMed

Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):407-13. . View in PubMed

Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):801-5. . View in PubMed

A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer Int J Radiat Oncol Biol Phys. 2013 Dec 01; 87(5):1043-50. . View in PubMed

Cosmetic analysis following breast-conserving surgery and adjuvant high-dose-rate interstitial brachytherapy for early-stage breast cancer: a prospective clinical study Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):965-70. . View in PubMed

Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma J Radiat Oncol. 2013 Mar; 2(1):27-34. . View in PubMed

Analysis of fat necrosis after adjuvant high-dose-rate interstitial brachytherapy for early stage breast cancer Brachytherapy. 2013 Mar-Apr; 12(2):99-106. . View in PubMed

Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis Radiat Oncol. 2013 Jan 03; 8:4. . View in PubMed

Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation Radiat Oncol. 2012 Mar 29; 7:53. . View in PubMed

Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes Pharmacogenomics. 2008 Oct; 9(10):1403-17. . View in PubMed

Four-dimensional computed tomography-based respiratory-gated whole-abdominal intensity-modulated radiation therapy for ovarian cancer: a feasibility study Int J Gynecol Cancer. 2007 Jan-Feb; 17(1):55-60. . View in PubMed

Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel Clin Cancer Res. 2005 Nov 15; 11(22):8097-104. . View in PubMed

CYP3A4 and CYP3A5 genotyping by Pyrosequencing BMC Med Genet. 2005 May 09; 6:19. . View in PubMed

Pyrosequencing of clinically relevant polymorphisms Methods Mol Biol. 2005; 311:97-114. . View in PubMed

Powered by SC CTSI
Go to Top